We have located links that may give you full text access.
Racial/ethnic disparities in vicarious and direct COVID-19-related discrimination and vigilance.
American Journal of Preventive Medicine 2023 March 23
INTRODUCTION: The high visibility of COVID-19-related discrimination underscores the importance of understanding the psychological harms associated with vicariously and directly experiencing such incidents. In this observational study, both vicariously and directly experienced COVID-19-related discrimination and their association with heightened concerns about discrimination and vigilance were examined in U.S. adults who use commercial tobacco.
METHODS: Data were from a nationally representative sample of adults who currently or formerly used commercial tobacco products (N=1,700; mean age = 43 years) from an online survey panel administered in January-February 2021 (analyzed in 2021-2022). Participants reported vicariously and directly experienced COVID-19-related discrimination, concern about experiencing such discrimination and heightened vigilance. Weighted multivariable linear and logistic regression models were used to examine associations among these variables.
RESULTS: Overall, 69% of individuals reported exposure to vicarious COVID-19-related discrimination and 22% reported directly experiencing COVID-19-related discrimination. Asian, Hispanic, and Black individuals reported higher levels of concern and vigilance compared to White individuals (P<0.05). Vicariously and directly experienced COVID-19-related discrimination were independently associated with concern about experiencing COVID-19-related discrimination in the entire sample and within each racial and ethnic group (P<0.05). This concern was associated with increased vigilance (P<0.05) and was stronger in those exposed to vicarious COVID-19-related discrimination versus those who were not (P<0.05).
CONCLUSIONS: COVID-19-related discrimination may undermine psychological well-being for those who are exposed to it vicariously, as well as those who experience it directly, and may also make individuals feel vulnerable and unsafe. Interventions to prevent and reduce the impact of COVID-19-related discrimination may have wide-reaching societal benefits.
METHODS: Data were from a nationally representative sample of adults who currently or formerly used commercial tobacco products (N=1,700; mean age = 43 years) from an online survey panel administered in January-February 2021 (analyzed in 2021-2022). Participants reported vicariously and directly experienced COVID-19-related discrimination, concern about experiencing such discrimination and heightened vigilance. Weighted multivariable linear and logistic regression models were used to examine associations among these variables.
RESULTS: Overall, 69% of individuals reported exposure to vicarious COVID-19-related discrimination and 22% reported directly experiencing COVID-19-related discrimination. Asian, Hispanic, and Black individuals reported higher levels of concern and vigilance compared to White individuals (P<0.05). Vicariously and directly experienced COVID-19-related discrimination were independently associated with concern about experiencing COVID-19-related discrimination in the entire sample and within each racial and ethnic group (P<0.05). This concern was associated with increased vigilance (P<0.05) and was stronger in those exposed to vicarious COVID-19-related discrimination versus those who were not (P<0.05).
CONCLUSIONS: COVID-19-related discrimination may undermine psychological well-being for those who are exposed to it vicariously, as well as those who experience it directly, and may also make individuals feel vulnerable and unsafe. Interventions to prevent and reduce the impact of COVID-19-related discrimination may have wide-reaching societal benefits.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app